Recent Updates
Recently added Catalysts
CHRS Positive Sentiment

Coherus Management to Participate in the 2024 Citi Global Healthcare Conference

Wednesday, November 27, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Coherus BioSciences, Inc. has announced that its senior management will participate in the upcoming 2024 Citi Global Healthcare Conference. Dr. Theresa LaVallee, the Chief Development Officer, will be part of the panel discussing Novel Mechanisms in Oncology on December 3, 2024. This event will be webcasted for accessible viewing through the company's website.
Price reaction · baseline $1.28 (2024-11-26 close) · hit after-hours · 1 other CHRS headline(s) in the window, move may be shared
day 0 close
-1.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus management is engaged in a significant healthcare event.
  • Participation in the Citi Global Healthcare Conference enhances visibility.
  • Discussion on Novel Mechanisms in Oncology indicates innovation focus.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis

Full Press Release Details

REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will participate in the 2024 Citi Global Healthcare Conference, with Dr. Theresa LaVallee, Chief Development Officer, sitting on the Novel Mechanisms in Oncology Panel on December 3, 2024, at 3:15 p.m. ET.
The panel discussion will be accessible via webcast through a link on the Investor Events and Presentations section of the Coherus website: https://investors.coherus.com/events-presentations.
Coherus Contact Information:

Frequently Asked Questions

When will Coherus participate in the Citi Global Healthcare Conference?

Coherus will participate on December 3, 2024.

Who from Coherus will be on the oncology panel?

Dr. Theresa LaVallee will represent Coherus on the panel.

How can I access the panel discussion?

The panel can be accessed via webcast on Coherus's website.

What time is the oncology panel scheduled?

The panel is scheduled for 3:15 p.m. ET.

What is Coherus's stock symbol?

Coherus's stock symbol is NASDAQ: CHRS.

ShareAdd on Google
Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences Citi Conference oncology 2024 events
Last updated: Nov 27, 2024

Biotech snapshot

Cash runway
$105M liquidity · $21M/mo burn
~5 mo
High dilution risk
Lead asset
CHS-0214Phase 3
Rheumatoid Arthritis →

Catalyst track record

+136%
best trade around CHRS's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for CHRS.

See every catalyst's timing & PoA →